L B Heifets

Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis

Angelo Scorpio, Pamela J. Lindholm-Levy, L B Heifets et al. · Antimicrobial Agents and Chemotherapy · 1997 · 329 citations · Full text

Pnca Gene, Pulmonary Tuberculosis, Antimicrobial Resistance Gene +14

Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens

Glenn D. Roberts, Norman Goodman, L B Heifets et al. · Journal of Clinical Microbiology · 1983 · 317 citations · Full text

Medical Microbiology, Pulmonary Tuberculosis, Drug Susceptibility Testing +15

Molecular Mechanisms of Clarithromycin Resistance in Mycobacterium avium: Observation of Multiple 238 rDNA Mutations in a Clonal Population

A Meier, L B Heifets, Richard J. Wallace et al. · The Journal of Infectious Diseases · 1996 · 115 citations · Full text

Bacteriology, Molecular Biology, Pathology +19

Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare.

L B Heifets · PubMed · 1982 · 63 citations

Actual Drug Resistance, Antimicrobial Chemotherapy, Drug Resistance +18

Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis?

L B Heifets, Marcella Flory, Pamela J. Lindholm-Levy · Antimicrobial Agents and Chemotherapy · 1989 · 62 citations · Full text

Specific Activity, Tuberculosis Prevention, Antimicrobial Chemotherapy +20